Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
JXSL2500078	Tremelimumab注射液	tremelimumab	Injection	Biological Products(2.2)	Import Drug Application	2025-05-20	Medimmune LLC;Astrazeneca Investment (China) Co Ltd	view
JXSS2500016	Tremelimumab注射液	tremelimumab	Injection	Biological Products(3.1)	Import Drug Application	2025-02-21	Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd	view
JXSS2500015	Tremelimumab注射液	tremelimumab	Injection	Biological Products(3.1)	Import Drug Application	2025-02-21	Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd	view
JXSL2400249	Tremelimumab注射液	tremelimumab	Injection	Biological Products(2.2)	Import Drug Application	2024-12-25	Medimmune LLC;Astrazeneca Investment (China) Co Ltd	view
JXSS2400097	Tremelimumab注射液	tremelimumab	Injection	Biological Products(3.1)	Import Drug Application	2024-10-18	Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd	view
JXSS2400099	Tremelimumab注射液	tremelimumab	Injection	Biological Products(3.1)	Import Drug Application	2024-10-18	Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd	view
JTS2400033	Tremelimumab注射液	tremelimumab	Injection	Biological Products	Disposable Import Drug Application	2024-04-13	Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd	view
JTS2400032	Tremelimumab注射液	tremelimumab	Injection	Biological Products	Disposable Import Drug Application	2024-04-13	Vetter Pharma-Fertigung Gmbh & Co KG;AstraZeneca AB;AstraZeneca Global R&D (China) Co Ltd	view